Hundreds of "wanted" posters covered a tunnel beneath the University of Rochester campus Sunday night, accusing a handful of ...
Curis, Inc. ("Curis") , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback